← Eichor
Study identifier: NCT06955884 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Patient Experience of Transoral Versus Transnasal Awake Tracheal Intubation

Condition: Airway Management · Fiberoptic Guided Intubation · Patient Experience  ·  Sponsor: Universitätsklinikum Hamburg-Eppendorf

PhaseN/A
Planned participants198
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Airway management problems are key drivers for anesthesia-related adverse events. Awake tracheal intubation using flexible bronchoscopy and preserved spontaneous breathing (ATI:FB) is a recommended technique to manage difficult tracheal intubation in anaesthesia, intensive care and emergency medicine. ATI:FB is regarded as the gold standard of tracheal intubation in many scenarios, however there is insufficient data on the patients experience while undergoing this form of airway management. ATI:FB can be facilitated using either a transnasal or transoral route. The study aims to compare patient-centred and operator-focused outcome parameters between these two different approaches with a focus on patient discomfort.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (1)

University Medical Center Hamburg-EppendorfHamburg, Free and Hanseatic City of Hamburg, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06955884